These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 2264267)

  • 41. Enhancement of saccharin removal from aqueous solution by activated carbon adsorption with ultrasonic treatment.
    Bernardo EC; Fukuta T; Fujita T; Ona EP; Kojima Y; Matsuda H
    Ultrason Sonochem; 2006 Jan; 13(1):13-8. PubMed ID: 16223680
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect on sodium sulphate on the adsorption of chloroquine and mefloquine to activated charcoal.
    Orisakwe OE; Akintonwa A
    East Afr Med J; 1991 Jun; 68(6):420-4. PubMed ID: 1752220
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Determination of the adsorption of tramadol hydrochloride by activated charcoal in vitro and in vivo.
    Raffa RB; Wu C; Stone DJ; Borenstein MR; Codd EE; Coogan TP
    J Pharmacol Toxicol Methods; 2000; 43(3):205-10. PubMed ID: 11257485
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The treatment of quinine poisoning with charcoal haemoperfusion.
    Morgan MD; Rainford DJ; Pusey CD; Robins-Cherry AM; Henry JG
    Postgrad Med J; 1983 Jun; 59(692):365-7. PubMed ID: 6634542
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Measures to reduce absorption in the treatment of intoxications].
    de Vries I; van Zoelen GA; van Riel AJ; Meulenbelt J
    Ned Tijdschr Geneeskd; 2005 Dec; 149(53):2964-8. PubMed ID: 16425848
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The pharmacokinetics of quinine and quinidine in malaria.
    White NJ
    Acta Leiden; 1987; 55():65-76. PubMed ID: 3321842
    [No Abstract]   [Full Text] [Related]  

  • 47. In vitro study of the effectiveness of three commercial adsorbents for binding oleander toxins.
    Tiwary AK; Poppenga RH; Puschner B
    Clin Toxicol (Phila); 2009 Mar; 47(3):213-8. PubMed ID: 19274509
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of quinine overdosage with repeated oral charcoal.
    Prescott LF; Hamilton AR; Heyworth R
    Br J Clin Pharmacol; 1989 Jan; 27(1):95-7. PubMed ID: 2706192
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The influence of alpha 1-acid glycoprotein on quinine and quinidine disposition in the rat isolated perfused liver preparation.
    Mansor SM; Ward SA; Edwards G; Hoaksey PE; Breckenridge AM
    J Pharm Pharmacol; 1991 Sep; 43(9):650-4. PubMed ID: 1685525
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activated carbon with excellent chromium(VI) adsorption performance prepared by acid-base surface modification.
    Liu SX; Chen X; Chen XY; Liu ZF; Wang HL
    J Hazard Mater; 2007 Mar; 141(1):315-9. PubMed ID: 16914264
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of activated charcoal on drug exposure in healthy volunteers: a meta-analysis.
    Jürgens G; Hoegberg LC; Graudal NA
    Clin Pharmacol Ther; 2009 May; 85(5):501-5. PubMed ID: 19194372
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effect of antidotes on the rate of absorption of 2,4-dinitrophenol from the digestive tract into the blood].
    Sen'chuk V; Adamska T
    Farmakol Toksikol; 1977; 40(4):425-7. PubMed ID: 902742
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparison of the pharmacokinetic and pharmacodynamic properties of quinine and quinidine in healthy Thai males.
    Karbwang J; Davis TM; Looareesuwan S; Molunto P; Bunnag D; White NJ
    Br J Clin Pharmacol; 1993 Mar; 35(3):265-71. PubMed ID: 8471402
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activated charcoal--a neglected antidote.
    Dipalma JR
    Am Fam Physician; 1979 Nov; 20(5):155-6. PubMed ID: 495394
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect of the aluminium ion on hepatic elimination of quinine and quinidine.
    Jakovljević V; Popović M; Sabo A; Banić B
    Eur J Drug Metab Pharmacokinet; 1995; 20(3):185-90. PubMed ID: 8751039
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Position paper: Single-dose activated charcoal.
    Chyka PA; Seger D; Krenzelok EP; Vale JA; ;
    Clin Toxicol (Phila); 2005; 43(2):61-87. PubMed ID: 15822758
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of fever on quinine and quinidine disposition in the rat.
    Mansor SM; Ward SA; Edwards G
    J Pharm Pharmacol; 1991 Oct; 43(10):705-8. PubMed ID: 1682445
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enhanced adsorptive capacity of activated charcoal in the presence of magnesium citrate, N.F.
    Ryan CF; Spigiel RW; Zeldes G
    Clin Toxicol; 1980 Oct; 17(3):457-61. PubMed ID: 7449359
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of malaria infection on the disposition of quinine and quinidine in the rat isolated perfused liver preparation.
    Mansor SM; Ward SA; Edwards G; Hoaksey PE; Breckenridge AM
    J Pharm Pharmacol; 1990 Jun; 42(6):428-32. PubMed ID: 1979624
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activated charcoal as the sole intervention for treatment after childhood poisoning.
    Burns MM
    Curr Opin Pediatr; 2000 Apr; 12(2):166-71. PubMed ID: 10763768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.